Navigation Links
VA National Campaign Takes Aim at Resistant Staph Infections
Date:10/18/2007

the Department began screening incoming patients to its intensive care units in March. The program has been expanded to other high-risk hospital units, including transplant and spinal cord injury as well as general surgical and medical patient wards.

For the latest news releases and other information, visit VA on the Internet at http://www.va.gov/opa.

To receive e-mail copies of news releases, subscribe to VA's list server at: http://www.va.gov/opa/pressrel/opalist_listserv.cfm.


'/>"/>
SOURCE Department of Veterans Affairs
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-F...q: BCRX ) today announced the pricing of a public...at $9.75 per share, resulting in gross proceeds of...red by BioCryst pursuant to an effective shelf reg...rities and Exchange Commission. BioCryst has also...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Binghamton Research Group Develops New Cancer Treatment 5010 1Binghamton Research Group Develops New Cancer Treatment 5010 2Binghamton Research Group Develops New Cancer Treatment 5010 3Binghamton Research Group Develops New Cancer Treatment 5010 4HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1Reactive oxygens role in metastasis 9946 1Reactive oxygens role in metastasis 9946 2
...ta Selected and Presented as,Platform Presentation...Technology,Demonstrates Optimal Functional Activit...-- Discovery,Laboratories, Inc. (Nasdaq:DSCO) anno...hase 2 clinical trial of Surfaxin(r),(lucinactant ...reatment of Bronchopulmonary Dysplasia (BPD) were ...
...May 8, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG)... clinical trial for its ALTACE(R) (ramipril),diure...merican,Society of Hypertension,s Twenty-Second An...ay 19, 2007 at the Hyatt Regency Hotel,Chicago, I... for,review from 10 AM to 6 PM CDT. The Company pr...
Other Medicine Technology:Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting 2
(Date:11/22/2009)...hysician-scientists from Weill Cornell Medical Col...y prove to be a powerful target for the treatment ...ffects lymphocytes, or white blood cells. By explo...o powerfully suppress tumor formation in lab testi...e led to the design of a clinical trial that will ...
(Date:11/22/2009)...& Machine post You Tube video demonstrating th... Landover, MD (PRWEB) Novemb...in learning what a really rugged waterproof keyboa...ool Keyboard vs Washable Competitors Keyboard HD&r...ow the premium, Really Cool Keyboard from Man &am...
(Date:11/21/2009)... Milvia Lopez, by her attorney MICH...led suit, in Supreme Court, New York County, beari... while Ms. Lopez underwent a routine transesophage...AL , doctors used an HIV infected scope exposing h...ral hours after being discharged from the procedur...
(Date:11/21/2009)...vative medical apparel company launches men,s lab ... San Clemente, Calif. (PRWEB) November 21,...cal apparel, today announced the launch of its men... a leading international trade fair for the medica...naugurates its men,s collection with three varying...
(Date:11/20/2009)...ist Closer to Understanding Brain Wiring and Disea...re/ -- Dr. Jeremy Schmahmann, Professor of Neurolo...e Massachusetts General Hospital in Boston, on Thu...earch on the new field of study called "Connectivi..., Dr. Schmahmann is an award-winning leader in the...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...ches new version of Infection Surveillance and Con...ONTO, Oct. 18 /PRNewswire/ - rL Solutions, the lea...tware, today announced the release of,Infection Mo...PW), running from October,14th to the 20th, is ent...
...Global Med Technologies(R),Inc. (OTC Bulletin Boar...mation technology company, announced today that it...as submitted its ElDorado Donor(TM),software for a...e FDA. ElDorado Donor is intended as a comprehens...
...Many people, including significant proportions of ...r from post-traumatic stress disorder (PTSD), ofte... While several drugs and psychotherapies are used...hat doesn,t, says a new report from the Institute ...
... N.J. A revolutionary, new biomaterial, developed... at Rutgers University, has moved from the lab ben...nt, a product of a breakthrough methodology in bio...ts are tiny tubes inserted into diseased arteries ...
...eveals heightened activity of neurotransmitter dop...s) -- Researchers have identified molecular mechan... are less vulnerable to the stress caused by diffi...he post-traumatic stress disorder suffered by troo...
...n. -- Mayo Clinic has clarified the methods of dia...-understood blood vessel disease of the brain and ...rimary central nervous system vasculitis (PCNSV) c... laboratory studies. , This disease is often susp...
Other Medicine News:Health News:Infection MonitorPro Version 1.1 Released during International Infection Prevention Week 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 3Health News:Effectiveness of most PTSD therapies is uncertain 2Health News:Effectiveness of most PTSD therapies is uncertain 3Health News:Rutgers biomaterial debuts in clinical trials of new stent 2Health News:Rutgers biomaterial debuts in clinical trials of new stent 3Health News:Vulnerability to Stress Linked to Brain Molecule 2Health News:Vulnerability to Stress Linked to Brain Molecule 3Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 2Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 3
Glucose (Liquid) Reagent
Glucose Hexokinase Reagent Set
Glucose UV Reagent
Glucose Color Reagent
Medicine Products: